These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 17463165)
1. Zinc inhibits doxorubicin-activated calcineurin signal transduction pathway in H9c2 embryonic rat cardiac cells. Merten KE; Jiang Y; Kang YJ Exp Biol Med (Maywood); 2007 May; 232(5):682-9. PubMed ID: 17463165 [TBL] [Abstract][Full Text] [Related]
2. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway. Merten KE; Jiang Y; Feng W; Kang YJ J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266 [TBL] [Abstract][Full Text] [Related]
3. Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway. Yoon JJ; Son CO; Kim HY; Han BH; Lee YJ; Lee HS; Kang DG Molecules; 2020 Dec; 26(1):. PubMed ID: 33374365 [TBL] [Abstract][Full Text] [Related]
5. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK. Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112 [TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway. Liu MH; Zhang Y; He J; Tan TP; Wu SJ; Guo DM; He H; Peng J; Tang ZH; Jiang ZS Int J Mol Med; 2016 Jun; 37(6):1661-8. PubMed ID: 27081862 [TBL] [Abstract][Full Text] [Related]
7. Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Kalivendi SV; Konorev EA; Cunningham S; Vanamala SK; Kaji EH; Joseph J; Kalyanaraman B Biochem J; 2005 Jul; 389(Pt 2):527-39. PubMed ID: 15799720 [TBL] [Abstract][Full Text] [Related]
8. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling. Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855 [TBL] [Abstract][Full Text] [Related]
9. Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells. Guo RM; Xu WM; Lin JC; Mo LQ; Hua XX; Chen PX; Wu K; Zheng DD; Feng JQ Mol Med Rep; 2013 Aug; 8(2):603-8. PubMed ID: 23807148 [TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells. Liu CJ; Cheng YC; Lee KW; Hsu HH; Chu CH; Tsai FJ; Tsai CH; Chu CY; Liu JY; Kuo WW; Huang CY Mol Cell Biochem; 2008 Jun; 313(1-2):167-78. PubMed ID: 18398669 [TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms regarding potassium bromate‑induced cardiac hypertrophy without apoptosis in H9c2 cells. Kuo SC; Li Y; Cheng YZ; Lee WJ; Cheng JT; Cheng KC Mol Med Rep; 2018 Nov; 18(5):4700-4708. PubMed ID: 30221729 [TBL] [Abstract][Full Text] [Related]
12. Punicalagin protects H9c2 cardiomyocytes from doxorubicin-induced toxicity through activation of Nrf2/HO-1 signaling. Ye M; Zhang L; Yan Y; Lin H Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015369 [TBL] [Abstract][Full Text] [Related]
13. MSCs enhances the protective effects of valsartan on attenuating the doxorubicin-induced myocardial injury via AngII/NOX/ROS/MAPK signaling pathway. Cheng D; Tu W; Chen L; Wang H; Wang Q; Liu H; Zhu N; Fang W; Yu Q Aging (Albany NY); 2021 Sep; 13(18):22556-22570. PubMed ID: 34587120 [TBL] [Abstract][Full Text] [Related]
14. Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes. Konorev EA; Vanamala S; Kalyanaraman B Free Radic Biol Med; 2008 Dec; 45(12):1723-8. PubMed ID: 18926904 [TBL] [Abstract][Full Text] [Related]
15. Hexane/ethanol extract of Glycyrrhiza uralensis licorice suppresses doxorubicin-induced apoptosis in H9c2 rat cardiac myoblasts. Choi HJ; Seon MR; Lim SS; Kim JS; Chun HS; Park JH Exp Biol Med (Maywood); 2008 Dec; 233(12):1554-60. PubMed ID: 18849542 [TBL] [Abstract][Full Text] [Related]
16. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades. Dai H; Jia G; Liu X; Liu Z; Wang H Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447 [TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-induces NFAT/Fas/FasL cardiac apoptosis in rats through activation of calcineurin and P38 MAPK and inhibition of mTOR signalling pathways. Shati AA Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):660-676. PubMed ID: 31811646 [TBL] [Abstract][Full Text] [Related]
18. CO and bilirubin inhibit doxorubicin-induced cardiac cell death. Kim DS; Chae SW; Kim HR; Chae HJ Immunopharmacol Immunotoxicol; 2009; 31(1):64-70. PubMed ID: 18756386 [TBL] [Abstract][Full Text] [Related]
19. Doxorubicin represses CARP gene transcription through the generation of oxidative stress in neonatal rat cardiac myocytes: possible role of serine/threonine kinase-dependent pathways. Aihara Y; Kurabayashi M; Tanaka T; Takeda SI; Tomaru K; Sekiguchi KI; Ohyama Y; Nagai R J Mol Cell Cardiol; 2000 Aug; 32(8):1401-14. PubMed ID: 10900167 [TBL] [Abstract][Full Text] [Related]